Mutational Spectrum And Dna-Based Prenatal Diagnosis In Carnitine-Acylcarnitine Translocase Deficiency

Molecular genetics and metabolism(2003)

引用 29|浏览7
暂无评分
摘要
Carnitine-acylcarnitine translocase (CAC) deficiency is a rare autosomal recessive disorder of long-chain fatty acid oxidation with a severe outcome. We report mutation analysis in a cohort of 12 patients. Twelve mutations were identified of which 9 have not been reported so far (G28C, D32N, R178Q, P230R, D231H, 179delG, 802delG, 69-70insTGTGC, and 609-1g > a). Altogether, including our results, 22 mutations of the CAC gene have been published to date in 23 patients demonstrating the allelic heterogeneity of CAC deficiency. DNA-based prenatal diagnosis was performed for the first time in pregnancies at risk for CAC deficiency. Two fetuses were affected and one pregnancy was terminated by family decision. Two other fetuses had normal genotype and five others were heterozygotes. All the offspring of these seven pregnancies are alive and apparently healthy. (C) 2002 Elsevier Science (USA). All rights reserved.
更多
查看译文
关键词
carnitine-acylcarnitine translocase,carnitine-acylcarnitine carrier,long-chain fatty acid oxidation,DNA-based prenatal diagnosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要